+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Analytical Testing Services Market Size, Share and Trends Analysis Report by Type (Medical Device Analytical Testing Services, Pharmaceutical Analytical Testing Services), and Region 2024-2030

  • PDF Icon

    Report

  • 130 Pages
  • September 2024
  • Region: Global
  • Grand View Research
  • ID: 5415555
The global healthcare analytical testing services market size is expected to reach USD 25.47 billion by 2030, expanding at a CAGR of 8.36% from 2024 to 2030. The increasing outsourcing of healthcare analytical testing services, growing demand for biosimilars, and rising number of clinical trials are some of the key factors that are driving the industry's growth. In addition, the COVID-19 pandemic contributed to the growth of the industry. Biosimilars are medications that have received FDA approval and share many biologic medicines’ approved features. When compared to biologics, they are a more affordable and effective treatment alternative, and it is projected that this will significantly increase demand in the coming years.

Analytical testing is highlighted as a crucial step in the development of biosimilars in a Sandoz International GmbH article, which increases demand for such services. The global COVID-19 pandemic is expected to offer high growth opportunities to the providers of such services. As pharmaceutical companies across the world have started clinical trials for the development of vaccines therapeutics, and medications for the treatment of COVID-19, the demand for analytical testing has increased. Also, to combat the coronavirus, the growing need to meet the global requirements of medical devices and pharmaceutical products, which must undergo rigorous testing before being distributed to customers, has boosted the production in the industry. This, in turn, is expected to augment the demand for such services.

Healthcare Analytical Testing Services Market Report Highlights

  • The medical device and pharmaceutical market has strict regulations so they are adopting analytical testing services that are driving the market growth.
  • The Pharmaceutical Analytical Testing Services market held the largest market share of 58.3% in 2023.
  • North America dominated the global market with the largest revenue share of 38.49% in 2023 owing to the presence of the largest clinical trials market in the U.S.
  • The Asia Pacific region is anticipated to grow at the fastest CAGR of 8.92% during the forecast period.
  • This growth can be credited to the development and expansion of new facilities in different countries present in this region.

The leading players in the Healthcare Analytical Testing Services market include:

  • PPD, Inc.
  • ICON plc
  • LabCorp
  • Charles River Laboratories International, Inc.
  • Syneos Health
  • SGS SA
  • Eurofins Scientific
  • Pace Analytical Services, LLC
  • Toxikon, Inc.
  • Intertek Group

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.3. Regional Scope
1.4. Estimates And Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
1.12. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Healthcare Analytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Healthcare Analytical Testing Services Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Healthcare Analytical Testing Services Market: Type Estimates & Trend Analysis
4.1. Healthcare Analytical Testing Services Market, By Type: Segment Dashboard
4.2. Healthcare Analytical Testing Services Market, By Type: Movement Analysis
4.3. Healthcare Analytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030
4.4. Medical Device Analytical Testing Services
4.4.1. Medical Device Analytical Testing Services Market, 2018 to 2030 (USD Million)
4.4.2. Extractable and Leachable
4.4.2.1. Extractable and Leachable Market, 2018 to 2030 (USD Million)
4.4.3. Material Characterization
4.4.3.1. Material Characterization Market, 2018 to 2030 (USD Million)
4.4.4. Physical Testing
4.4.4.1. Physical Testing Market, 2018 to 2030 (USD Million)
4.4.5. Bioburden Testing
4.4.5.1. Bioburden Testing Market, 2018 to 2030 (USD Million)
4.4.6. Sterility Testing
4.4.6.1. Sterility Testing Market, 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Others Market, 2018 to 2030 (USD Million)
4.5. Pharmaceutical Analytical Testing Services
4.5.1. Pharmaceutical Analytical Testing Services Market, 2018 to 2030 (USD Million)
4.5.2. Bioanalytical Testing
4.5.2.1. Bioanalytical Testing Market, 2018 to 2030 (USD Million)
4.5.3. Method Development and Validation
4.5.3.1. Method Development and Validation Market, 2018 to 2030 (USD Million)
4.5.4. Stability Testing
4.5.4.1. Stability Testing Market, 2018 to 2030 (USD Million)
4.5.5. Other Testing Services
4.5.5.1. Other Testing Services Market, 2018 to 2030 (USD Million)
Chapter 5. Healthcare Analytical Testing Services Market: Regional Estimates & Trend Analysis
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. North America
5.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
5.4.2. U.S.
5.4.2.1. Key Country Dynamics
5.4.2.2. Competitive Scenario
5.4.2.3. Regulatory Framework
5.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
5.4.3. Canada
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Framework
5.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
5.4.4. Mexico
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Framework
5.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030
5.5. Europe
5.5.1. UK
5.5.1.1. Key Country Dynamics
5.5.1.2. Competitive Scenario
5.5.1.3. Regulatory Framework
5.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
5.5.2. Germany
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Framework
5.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
5.5.3. France
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
5.5.4. Italy
5.5.4.1. Key Country Dynamics
5.5.4.2. Competitive Scenario
5.5.4.3. Regulatory Framework
5.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
5.5.5. Spain
5.5.5.1. Key Country Dynamics
5.5.5.2. Competitive Scenario
5.5.5.3. Regulatory Framework
5.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
5.5.6. Sweden
5.5.6.1. Key Country Dynamics
5.5.6.2. Competitive Scenario
5.5.6.3. Regulatory Framework
5.5.6.4. Sweden Market Estimates and Forecasts, 2018 - 2030
5.5.7. Denmark
5.5.7.1. Key Country Dynamics
5.5.7.2. Competitive Scenario
5.5.7.3. Regulatory Framework
5.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
5.5.8. Norway
5.5.8.1. Key Country Dynamics
5.5.8.2. Competitive Scenario
5.5.8.3. Regulatory Framework
5.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
5.6. Asia Pacific
5.6.1. Japan
5.6.1.1. Key Country Dynamics
5.6.1.2. Competitive Scenario
5.6.1.3. Regulatory Framework
5.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
5.6.2. China
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Framework
5.6.2.4. China Market Estimates and Forecasts, 2018 - 2030
5.6.3. India
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. India Market Estimates and Forecasts, 2018 - 2030
5.6.4. Thailand
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Framework
5.6.4.4. Thailand Market Estimates and Forecasts, 2018 - 2030
5.6.5. South Korea
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Framework
5.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030
5.6.6. Australia
5.6.6.1. Key Country Dynamics
5.6.6.2. Competitive Scenario
5.6.6.3. Regulatory Framework
5.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Key Country Dynamics
5.7.1.2. Competitive Scenario
5.7.1.3. Regulatory Framework
5.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
5.7.2. Argentina
5.7.2.1. Key Country Dynamics
5.7.2.2. Competitive Scenario
5.7.2.3. Regulatory Framework
5.7.2.4. Argentina Market Estimates and Forecasts, 2018 - 2030
5.8. MEA
5.8.1. South Africa
5.8.1.1. Key Country Dynamics
5.8.1.2. Competitive Scenario
5.8.1.3. Regulatory Framework
5.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
5.8.2. Saudi Arabia
5.8.2.1. Key Country Dynamics
5.8.2.2. Competitive Scenario
5.8.2.3. Regulatory Framework
5.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
5.8.3. UAE
5.8.3.1. Key Country Dynamics
5.8.3.2. Competitive Scenario
5.8.3.3. Regulatory Framework
5.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
5.8.4. Kuwait
5.8.4.1. Key Country Dynamics
5.8.4.2. Competitive Scenario
5.8.4.3. Regulatory Framework
5.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
Chapter 6. Competitive Landscape
6.1. Market Participant Categorization
6.1.1. Innovators
6.1.2. Market Leaders
6.1.3. Emerging Players
6.1.4. Company Market Share Analysis, 2023
6.2. Company Profiles
6.2.1. PPD, Inc.
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Service Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. ICON plc
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Service Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. LabCorp
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Service Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. Charles River Laboratories International, Inc.
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Service Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. Syneos Health
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Service Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. SGS SA
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Service Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. Eurofins Scientific
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Service Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Pace Analytical Services, LLC
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Service Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Toxikon, Inc.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Service Benchmarking
6.2.9.4. Strategic Initiatives
6.2.10. Intertek Group
6.2.10.1. Company Overview
6.2.10.2. Financial Performance
6.2.10.3. Service Benchmarking
6.2.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 4 Global Healthcare Analytical Testing Services,by Region, 2018 - 2030 (USD Million)
Table 5 North America Healthcare Analytical Testing Services,by Country, 2018 - 2030 (USD Million)
Table 6 North America Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 7 U.S Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 8 Canada Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 9 Mexico Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 10 Europe Healthcare Analytical Testing Services,by Country, 2018 - 2030 (USD Million)
Table 11 Europe Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 12 UK Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 13 Germany Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 14 France Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 15 Italy Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 16 Spain Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 17 Sweden Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 18 Denmark Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 19 Norway Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 20 Asia Pacific Healthcare Analytical Testing Services,by Country, 2018 - 2030 (USD Million)
Table 21 Asia Pacific Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 22 Japan Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 23 China Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 24 India Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 25 Thailand Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 26 South Korea Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 27 Australia Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 28 Latin America Healthcare Analytical Testing Services,by Country, 2018 - 2030 (USD Million)
Table 29 Latin America Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 30 Brazil Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 31 Argentina Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 32 Middle East & Africa Healthcare Analytical Testing Services,by Country, 2018 - 2030 (USD Million)
Table 33 Middle East & Africa Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 34 South Africa Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 35 Saudi Arabia Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 36 UAE Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
Table 37 Kuwait Healthcare Analytical Testing Services,by Type, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Healthcare Analytical Testing Services Market revenue, 2018 - 2030 (USD Million)
Fig. 10 Healthcare Analytical Testing Services Market snapshot
Fig. 11 Healthcare Analytical Testing Services Market driver impact
Fig. 12 Healthcare Analytical Testing Services Market restraint impact
Fig. 13 Healthcare Analytical Testing Services sector key takeaways (USD Million)
Fig. 14 Healthcare Analytical Testing Services Market: Type movement analysis
Fig. 15 Medical device analytical testing services market, 2018 - 2030 (USD Million)
Fig. 16 Extractable and leachable market, 2018 - 2030 (USD Million)
Fig. 17 Material characterization market, 2018 - 2030 (USD Million)
Fig. 18 Physical testing market, 2018 - 2030 (USD Million)
Fig. 19 Bioburden testing market, 2018 - 2030 (USD Million)
Fig. 20 Sterility testing market, 2018 - 2030 (USD Million)
Fig. 21 Other tests market, 2018 - 2030 (USD Million)
Fig. 22 Pharmaceutical analytical testing services market, 2018 - 2030 (USD Million)
Fig. 23 Bioanalytical testing market, 2018 - 2030 (USD Million)
Fig. 24 Method development and validation market, 2018 - 2030 (USD Million)
Fig. 25 Stability testing market, 2018 - 2030 (USD Million)
Fig. 26 Other testing services market, 2018 - 2030 (USD Million)
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 Regional outlook, 2023 & 2030
Fig. 29 North America Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 30 U.S. Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 31 Canada Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 32 Mexico Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 33 Europe Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 34 UK Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 35 Germany Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 36 France Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 37 Italy Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 38 Spain companion animal Health market, 2018 - 2030 (USD Million)
Fig. 39 Sweden Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 40 Denmark Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 41 Norway Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 43 Japan Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 44 China Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 45 India Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 46 Thailand Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 47 South Korea Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 48 Australia Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 49 Latin America Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 50 Brazil Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 51 Argentina Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 52 Middle East & Africa Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 53 South Africa Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 55 UAE Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 56 Kuwait Healthcare Analytical Testing Services Market, 2018 - 2030 (USD Million)
Fig. 57 Market participant categorization

Companies Mentioned

The leading players in the Healthcare Analytical Testing Services market include:
  • PPD, Inc.
  • ICON plc
  • LabCorp
  • Charles River Laboratories International, Inc.
  • Syneos Health
  • SGS SA
  • Eurofins Scientific
  • Pace Analytical Services, LLC
  • Toxikon, Inc.
  • Intertek Group

Methodology

Loading
LOADING...

Table Information